nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.212	0.565	CbGaD
Loxapine—HTR2A—chronic obstructive pulmonary disease	0.163	0.435	CbGaD
Loxapine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0832	0.2	CbGbCtD
Loxapine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0766	0.184	CbGbCtD
Loxapine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0631	0.151	CbGbCtD
Loxapine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0631	0.151	CbGbCtD
Loxapine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.049	0.117	CbGbCtD
Loxapine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0426	0.102	CbGbCtD
Loxapine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0393	0.0942	CbGbCtD
Loxapine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00546	0.205	CbGeAlD
Loxapine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00318	0.12	CbGeAlD
Loxapine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00198	0.0745	CbGeAlD
Loxapine—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.000827	0.0311	CbGeAlD
Loxapine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.00784	CcSEcCtD
Loxapine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000709	0.00775	CcSEcCtD
Loxapine—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000697	0.00762	CcSEcCtD
Loxapine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000688	0.0259	CbGeAlD
Loxapine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000669	0.00731	CcSEcCtD
Loxapine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000661	0.00722	CcSEcCtD
Loxapine—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00722	CcSEcCtD
Loxapine—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00066	0.00721	CcSEcCtD
Loxapine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000648	0.00708	CcSEcCtD
Loxapine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000631	0.0069	CcSEcCtD
Loxapine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000631	0.0237	CbGeAlD
Loxapine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000623	0.00681	CcSEcCtD
Loxapine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.00681	CcSEcCtD
Loxapine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.000608	0.00664	CcSEcCtD
Loxapine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000591	0.0222	CbGeAlD
Loxapine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00643	CcSEcCtD
Loxapine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000575	0.0216	CbGeAlD
Loxapine—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000563	0.00615	CcSEcCtD
Loxapine—HRH2—lung—chronic obstructive pulmonary disease	0.000559	0.021	CbGeAlD
Loxapine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000556	0.00607	CcSEcCtD
Loxapine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000555	0.0209	CbGeAlD
Loxapine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000539	0.00589	CcSEcCtD
Loxapine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000537	0.0202	CbGeAlD
Loxapine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000535	0.0201	CbGeAlD
Loxapine—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.00582	CcSEcCtD
Loxapine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000506	0.019	CbGeAlD
Loxapine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000497	0.00543	CcSEcCtD
Loxapine—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000483	0.00527	CcSEcCtD
Loxapine—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.00527	CcSEcCtD
Loxapine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000475	0.00519	CcSEcCtD
Loxapine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00518	CcSEcCtD
Loxapine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000471	0.0177	CbGeAlD
Loxapine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00047	0.00514	CcSEcCtD
Loxapine—CHRM1—trachea—chronic obstructive pulmonary disease	0.000464	0.0174	CbGeAlD
Loxapine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000456	0.00498	CcSEcCtD
Loxapine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00498	CcSEcCtD
Loxapine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000453	0.00495	CcSEcCtD
Loxapine—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000453	0.017	CbGeAlD
Loxapine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000442	0.00482	CcSEcCtD
Loxapine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00482	CcSEcCtD
Loxapine—HTR3A—lung—chronic obstructive pulmonary disease	0.000439	0.0165	CbGeAlD
Loxapine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00479	CcSEcCtD
Loxapine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000431	0.0162	CbGeAlD
Loxapine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00468	CcSEcCtD
Loxapine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000421	0.0046	CcSEcCtD
Loxapine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00456	CcSEcCtD
Loxapine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00451	CcSEcCtD
Loxapine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.00451	CcSEcCtD
Loxapine—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00447	CcSEcCtD
Loxapine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000405	0.00443	CcSEcCtD
Loxapine—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000405	0.0152	CbGeAlD
Loxapine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.0044	CcSEcCtD
Loxapine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000399	0.015	CbGeAlD
Loxapine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00436	CcSEcCtD
Loxapine—HTR7—trachea—chronic obstructive pulmonary disease	0.000395	0.0149	CbGeAlD
Loxapine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000394	0.00431	CcSEcCtD
Loxapine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00425	CcSEcCtD
Loxapine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000385	0.0042	CcSEcCtD
Loxapine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000383	0.00418	CcSEcCtD
Loxapine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00415	CcSEcCtD
Loxapine—Asenapine—ADRB2—chronic obstructive pulmonary disease	0.00038	0.092	CrCbGaD
Loxapine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000372	0.00407	CcSEcCtD
Loxapine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00404	CcSEcCtD
Loxapine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00403	CcSEcCtD
Loxapine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.004	CcSEcCtD
Loxapine—SLC6A3—lung—chronic obstructive pulmonary disease	0.000365	0.0137	CbGeAlD
Loxapine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000364	0.00397	CcSEcCtD
Loxapine—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000363	0.0137	CbGeAlD
Loxapine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00394	CcSEcCtD
Loxapine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00394	CcSEcCtD
Loxapine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00393	CcSEcCtD
Loxapine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00391	CcSEcCtD
Loxapine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00387	CcSEcCtD
Loxapine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00387	CcSEcCtD
Loxapine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00385	CcSEcCtD
Loxapine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000352	0.0132	CbGeAlD
Loxapine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00383	CcSEcCtD
Loxapine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00035	0.00382	CcSEcCtD
Loxapine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00379	CcSEcCtD
Loxapine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000347	0.00379	CcSEcCtD
Loxapine—ADRB1—lung—chronic obstructive pulmonary disease	0.000347	0.013	CbGeAlD
Loxapine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000346	0.00378	CcSEcCtD
Loxapine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000346	0.00378	CcSEcCtD
Loxapine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000345	0.013	CbGeAlD
Loxapine—Asenapine—SLC6A4—chronic obstructive pulmonary disease	0.000345	0.0835	CrCbGaD
Loxapine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000344	0.00376	CcSEcCtD
Loxapine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.00374	CcSEcCtD
Loxapine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00372	CcSEcCtD
Loxapine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.0037	CcSEcCtD
Loxapine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00369	CcSEcCtD
Loxapine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00368	CcSEcCtD
Loxapine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00367	CcSEcCtD
Loxapine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00367	CcSEcCtD
Loxapine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00366	CcSEcCtD
Loxapine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00366	CcSEcCtD
Loxapine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000335	0.0126	CbGeAlD
Loxapine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00365	CcSEcCtD
Loxapine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000334	0.0125	CbGeAlD
Loxapine—CHRM1—lung—chronic obstructive pulmonary disease	0.000334	0.0125	CbGeAlD
Loxapine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00362	CcSEcCtD
Loxapine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00359	CcSEcCtD
Loxapine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00359	CcSEcCtD
Loxapine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000327	0.00357	CcSEcCtD
Loxapine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000323	0.0121	CbGeAlD
Loxapine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00352	CcSEcCtD
Loxapine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000322	0.0121	CbGeAlD
Loxapine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.0035	CcSEcCtD
Loxapine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00032	0.0035	CcSEcCtD
Loxapine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00346	CcSEcCtD
Loxapine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00345	CcSEcCtD
Loxapine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00343	CcSEcCtD
Loxapine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00343	CcSEcCtD
Loxapine—Asenapine—CYP1A2—chronic obstructive pulmonary disease	0.000314	0.0761	CrCbGaD
Loxapine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00343	CcSEcCtD
Loxapine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00342	CcSEcCtD
Loxapine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00339	CcSEcCtD
Loxapine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00339	CcSEcCtD
Loxapine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00336	CcSEcCtD
Loxapine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.0033	CcSEcCtD
Loxapine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000299	0.00326	CcSEcCtD
Loxapine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00326	CcSEcCtD
Loxapine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00326	CcSEcCtD
Loxapine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00324	CcSEcCtD
Loxapine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00323	CcSEcCtD
Loxapine—HRH1—trachea—chronic obstructive pulmonary disease	0.000295	0.0111	CbGeAlD
Loxapine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00323	CcSEcCtD
Loxapine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00323	CcSEcCtD
Loxapine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000295	0.0111	CbGeAlD
Loxapine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000294	0.011	CbGeAlD
Loxapine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00319	CcSEcCtD
Loxapine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00318	CcSEcCtD
Loxapine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00318	CcSEcCtD
Loxapine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00317	CcSEcCtD
Loxapine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.00029	0.0109	CbGeAlD
Loxapine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00316	CcSEcCtD
Loxapine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00311	CcSEcCtD
Loxapine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00311	CcSEcCtD
Loxapine—HTR7—lung—chronic obstructive pulmonary disease	0.000284	0.0107	CbGeAlD
Loxapine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.0031	CcSEcCtD
Loxapine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00308	CcSEcCtD
Loxapine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00305	CcSEcCtD
Loxapine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00305	CcSEcCtD
Loxapine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00305	CcSEcCtD
Loxapine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.003	CcSEcCtD
Loxapine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00299	CcSEcCtD
Loxapine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00299	CcSEcCtD
Loxapine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00299	CcSEcCtD
Loxapine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00298	CcSEcCtD
Loxapine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00298	CcSEcCtD
Loxapine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00027	0.00295	CcSEcCtD
Loxapine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00294	CcSEcCtD
Loxapine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000269	0.0101	CbGeAlD
Loxapine—DRD2—lung—chronic obstructive pulmonary disease	0.000269	0.0101	CbGeAlD
Loxapine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00293	CcSEcCtD
Loxapine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00292	CcSEcCtD
Loxapine—Asenapine—HTR2A—chronic obstructive pulmonary disease	0.000265	0.0642	CrCbGaD
Loxapine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00288	CcSEcCtD
Loxapine—ADRA2C—lung—chronic obstructive pulmonary disease	0.000261	0.00981	CbGeAlD
Loxapine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00285	CcSEcCtD
Loxapine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00285	CcSEcCtD
Loxapine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00283	CcSEcCtD
Loxapine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00283	CcSEcCtD
Loxapine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00282	CcSEcCtD
Loxapine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00281	CcSEcCtD
Loxapine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.00278	CcSEcCtD
Loxapine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00276	CcSEcCtD
Loxapine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00276	CcSEcCtD
Loxapine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00272	CcSEcCtD
Loxapine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00272	CcSEcCtD
Loxapine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00271	CcSEcCtD
Loxapine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00271	CcSEcCtD
Loxapine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000247	0.0027	CcSEcCtD
Loxapine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000247	0.00927	CbGeAlD
Loxapine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00269	CcSEcCtD
Loxapine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00268	CcSEcCtD
Loxapine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00267	CcSEcCtD
Loxapine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00265	CcSEcCtD
Loxapine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00265	CcSEcCtD
Loxapine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.00264	CcSEcCtD
Loxapine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00263	CcSEcCtD
Loxapine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00263	CcSEcCtD
Loxapine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00263	CcSEcCtD
Loxapine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00263	CcSEcCtD
Loxapine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00261	CcSEcCtD
Loxapine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00261	CcSEcCtD
Loxapine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.0026	CcSEcCtD
Loxapine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00259	CcSEcCtD
Loxapine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00258	CcSEcCtD
Loxapine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00257	CcSEcCtD
Loxapine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00257	CcSEcCtD
Loxapine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00256	CcSEcCtD
Loxapine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000233	0.00255	CcSEcCtD
Loxapine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00253	CcSEcCtD
Loxapine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00252	CcSEcCtD
Loxapine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00251	CcSEcCtD
Loxapine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00251	CcSEcCtD
Loxapine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00023	0.00251	CcSEcCtD
Loxapine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.0025	CcSEcCtD
Loxapine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00249	CcSEcCtD
Loxapine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00248	CcSEcCtD
Loxapine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00246	CcSEcCtD
Loxapine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.0024	CcSEcCtD
Loxapine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00238	CcSEcCtD
Loxapine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.00238	CcSEcCtD
Loxapine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.00238	CcSEcCtD
Loxapine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.00238	CcSEcCtD
Loxapine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00237	CcSEcCtD
Loxapine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000217	0.00237	CcSEcCtD
Loxapine—HRH1—lung—chronic obstructive pulmonary disease	0.000212	0.00797	CbGeAlD
Loxapine—Azelastine—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.0511	CrCbGaD
Loxapine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000208	0.00783	CbGeAlD
Loxapine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00225	CcSEcCtD
Loxapine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00225	CcSEcCtD
Loxapine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00224	CcSEcCtD
Loxapine—Azelastine—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.0493	CrCbGaD
Loxapine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000201	0.0022	CcSEcCtD
Loxapine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00219	CcSEcCtD
Loxapine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00219	CcSEcCtD
Loxapine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00216	CcSEcCtD
Loxapine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00216	CcSEcCtD
Loxapine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Loxapine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00212	CcSEcCtD
Loxapine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00211	CcSEcCtD
Loxapine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00207	CcSEcCtD
Loxapine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00204	CcSEcCtD
Loxapine—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000185	0.0449	CrCbGaD
Loxapine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00202	CcSEcCtD
Loxapine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00202	CcSEcCtD
Loxapine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00197	CcSEcCtD
Loxapine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00194	CcSEcCtD
Loxapine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00194	CcSEcCtD
Loxapine—HTR2A—lung—chronic obstructive pulmonary disease	0.000177	0.00666	CbGeAlD
Loxapine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Loxapine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Loxapine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Loxapine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Loxapine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Loxapine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00191	CcSEcCtD
Loxapine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00191	CcSEcCtD
Loxapine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00191	CcSEcCtD
Loxapine—Olanzapine—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.0423	CrCbGaD
Loxapine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00191	CcSEcCtD
Loxapine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.0019	CcSEcCtD
Loxapine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000174	0.0019	CcSEcCtD
Loxapine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00188	CcSEcCtD
Loxapine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00188	CcSEcCtD
Loxapine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00187	CcSEcCtD
Loxapine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00183	CcSEcCtD
Loxapine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00182	CcSEcCtD
Loxapine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Loxapine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Loxapine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Loxapine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Loxapine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.0018	CcSEcCtD
Loxapine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Loxapine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00177	CcSEcCtD
Loxapine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00175	CcSEcCtD
Loxapine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00175	CcSEcCtD
Loxapine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.0383	CrCbGaD
Loxapine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00171	CcSEcCtD
Loxapine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000155	0.0375	CrCbGaD
Loxapine—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000153	0.037	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—chronic obstructive pulmonary disease	0.000152	0.0369	CrCbGaD
Loxapine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00165	CcSEcCtD
Loxapine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00162	CcSEcCtD
Loxapine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00161	CcSEcCtD
Loxapine—Olanzapine—HTR2A—chronic obstructive pulmonary disease	0.000147	0.0357	CrCbGaD
Loxapine—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000142	0.0345	CrCbGaD
Loxapine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00153	CcSEcCtD
Loxapine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00149	CcSEcCtD
Loxapine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00149	CcSEcCtD
Loxapine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00148	CcSEcCtD
Loxapine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000133	0.0323	CrCbGaD
Loxapine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00139	CcSEcCtD
Loxapine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00136	CcSEcCtD
Loxapine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00135	CcSEcCtD
Loxapine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Loxapine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00129	CcSEcCtD
Loxapine—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000117	0.0284	CrCbGaD
Loxapine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00127	CcSEcCtD
Loxapine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00127	CcSEcCtD
Loxapine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00122	CcSEcCtD
Loxapine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00011	0.0012	CcSEcCtD
Loxapine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.0265	CrCbGaD
Loxapine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00118	CcSEcCtD
Loxapine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00118	CcSEcCtD
Loxapine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Loxapine—Olanzapine—ALB—chronic obstructive pulmonary disease	0.000101	0.0244	CrCbGaD
Loxapine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.00109	CcSEcCtD
Loxapine—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.00109	CcSEcCtD
Loxapine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.00108	CcSEcCtD
Loxapine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.53e-05	0.00104	CcSEcCtD
Loxapine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.52e-05	0.00104	CcSEcCtD
Loxapine—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.00103	CcSEcCtD
Loxapine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.47e-05	0.00103	CcSEcCtD
Loxapine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	9.46e-05	0.0229	CrCbGaD
Loxapine—Constipation—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.00103	CcSEcCtD
Loxapine—Diazepam—CYP1A2—chronic obstructive pulmonary disease	9.23e-05	0.0224	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	9.22e-05	0.0223	CrCbGaD
Loxapine—Thiothixene—ALB—chronic obstructive pulmonary disease	9.13e-05	0.0221	CrCbGaD
Loxapine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	9.12e-05	0.0221	CrCbGaD
Loxapine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000989	CcSEcCtD
Loxapine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.98e-05	0.000981	CcSEcCtD
Loxapine—Quetiapine—HTR2A—chronic obstructive pulmonary disease	8.95e-05	0.0217	CrCbGaD
Loxapine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000884	CcSEcCtD
Loxapine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000861	CcSEcCtD
Loxapine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000849	CcSEcCtD
Loxapine—Clozapine—HTR2A—chronic obstructive pulmonary disease	7.7e-05	0.0186	CrCbGaD
Loxapine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000793	CcSEcCtD
Loxapine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000763	CcSEcCtD
Loxapine—Rash—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000757	CcSEcCtD
Loxapine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000756	CcSEcCtD
Loxapine—Headache—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000752	CcSEcCtD
Loxapine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000713	CcSEcCtD
Loxapine—Diazepam—ALB—chronic obstructive pulmonary disease	5.33e-05	0.0129	CrCbGaD
Loxapine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.85e-06	5.66e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.82e-06	5.62e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.82e-06	5.62e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.82e-06	5.61e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.79e-06	5.59e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	4.79e-06	5.58e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.78e-06	5.57e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.77e-06	5.55e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.75e-06	5.54e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.75e-06	5.54e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.75e-06	5.54e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.75e-06	5.53e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.73e-06	5.52e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.73e-06	5.51e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.72e-06	5.5e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.71e-06	5.49e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.71e-06	5.49e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.7e-06	5.48e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.69e-06	5.46e-05	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.69e-06	5.46e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.68e-06	5.46e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.68e-06	5.46e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.68e-06	5.45e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.67e-06	5.45e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.59e-06	5.34e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.55e-06	5.3e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.54e-06	5.28e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.52e-06	5.27e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.51e-06	5.26e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.49e-06	5.24e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.49e-06	5.23e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.48e-06	5.23e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.48e-06	5.22e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.46e-06	5.2e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.45e-06	5.19e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.45e-06	5.19e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.44e-06	5.17e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.4e-06	5.13e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.36e-06	5.08e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.34e-06	5.06e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.34e-06	5.06e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.33e-06	5.05e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.33e-06	5.04e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.32e-06	5.03e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.29e-06	5e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.29e-06	5e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.27e-06	4.98e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.26e-06	4.97e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.24e-06	4.94e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.23e-06	4.93e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.22e-06	4.91e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.2e-06	4.89e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.14e-06	4.83e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.13e-06	4.81e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.12e-06	4.8e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.08e-06	4.76e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	4.07e-06	4.74e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.06e-06	4.73e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.06e-06	4.73e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.03e-06	4.7e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.03e-06	4.69e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.01e-06	4.67e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.01e-06	4.67e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4e-06	4.66e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.99e-06	4.65e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.97e-06	4.63e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.95e-06	4.6e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.94e-06	4.6e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.93e-06	4.58e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.92e-06	4.57e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.92e-06	4.56e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.91e-06	4.55e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.89e-06	4.54e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	4.54e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.86e-06	4.5e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.86e-06	4.49e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.85e-06	4.49e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.84e-06	4.48e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.84e-06	4.48e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.81e-06	4.44e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.81e-06	4.44e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.81e-06	4.43e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.8e-06	4.43e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.75e-06	4.37e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.74e-06	4.36e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.73e-06	4.34e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.72e-06	4.33e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.7e-06	4.31e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.7e-06	4.31e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.68e-06	4.29e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.67e-06	4.28e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.67e-06	4.28e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.67e-06	4.28e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.65e-06	4.26e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.65e-06	4.26e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.64e-06	4.24e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.64e-06	4.24e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.63e-06	4.24e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.63e-06	4.23e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.62e-06	4.22e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.62e-06	4.22e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.61e-06	4.21e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.6e-06	4.19e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.59e-06	4.19e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.58e-06	4.17e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.57e-06	4.16e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.57e-06	4.16e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.56e-06	4.15e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.55e-06	4.14e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.55e-06	4.13e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.54e-06	4.12e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.52e-06	4.11e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.51e-06	4.09e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.5e-06	4.08e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.5e-06	4.08e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.49e-06	4.07e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.49e-06	4.07e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.48e-06	4.05e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.47e-06	4.05e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.47e-06	4.04e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.47e-06	4.04e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.44e-06	4.01e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.42e-06	3.99e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.42e-06	3.99e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.41e-06	3.97e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.38e-06	3.94e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.34e-06	3.89e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.33e-06	3.88e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.32e-06	3.87e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.31e-06	3.85e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.28e-06	3.82e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.26e-06	3.79e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.23e-06	3.76e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.22e-06	3.75e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.18e-06	3.71e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.17e-06	3.7e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.17e-06	3.69e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.16e-06	3.69e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.16e-06	3.68e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.15e-06	3.67e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.14e-06	3.66e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.12e-06	3.64e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.12e-06	3.64e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.12e-06	3.63e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.11e-06	3.62e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.09e-06	3.6e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.08e-06	3.59e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.07e-06	3.57e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.05e-06	3.55e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.04e-06	3.55e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.02e-06	3.52e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.02e-06	3.52e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.01e-06	3.51e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3e-06	3.5e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.99e-06	3.49e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.98e-06	3.48e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.97e-06	3.46e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.96e-06	3.45e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.96e-06	3.45e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.95e-06	3.44e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.92e-06	3.4e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.91e-06	3.39e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.89e-06	3.36e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.89e-06	3.36e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.87e-06	3.35e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.87e-06	3.35e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.86e-06	3.34e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.86e-06	3.34e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.86e-06	3.33e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.85e-06	3.32e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.84e-06	3.31e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.84e-06	3.31e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.82e-06	3.28e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.81e-06	3.28e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.81e-06	3.27e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.79e-06	3.25e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.78e-06	3.25e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.78e-06	3.24e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.77e-06	3.22e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.75e-06	3.21e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.75e-06	3.2e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.74e-06	3.19e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.72e-06	3.17e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.71e-06	3.16e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.69e-06	3.13e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.67e-06	3.11e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.67e-06	3.11e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.65e-06	3.09e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.63e-06	3.06e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.62e-06	3.06e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.62e-06	3.05e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.61e-06	3.04e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.61e-06	3.04e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.6e-06	3.03e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.59e-06	3.01e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.58e-06	3e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.57e-06	3e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.56e-06	2.99e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.56e-06	2.98e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.56e-06	2.98e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.53e-06	2.95e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.52e-06	2.94e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.52e-06	2.93e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.4e-06	2.8e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.4e-06	2.8e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.37e-06	2.76e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.37e-06	2.76e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.36e-06	2.75e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.36e-06	2.75e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.36e-06	2.75e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.35e-06	2.74e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.35e-06	2.73e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.35e-06	2.73e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.34e-06	2.72e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.32e-06	2.71e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.32e-06	2.7e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.32e-06	2.7e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.31e-06	2.7e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.31e-06	2.69e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.3e-06	2.68e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.28e-06	2.65e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.27e-06	2.65e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.25e-06	2.63e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.24e-06	2.61e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.18e-06	2.54e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.16e-06	2.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.15e-06	2.51e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.15e-06	2.5e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.14e-06	2.49e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.11e-06	2.46e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.06e-06	2.4e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.05e-06	2.39e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2e-06	2.33e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.98e-06	2.31e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.97e-06	2.29e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.95e-06	2.27e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.94e-06	2.26e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.94e-06	2.26e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.93e-06	2.25e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.91e-06	2.23e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.91e-06	2.22e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.81e-06	2.11e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.78e-06	2.08e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.78e-06	2.07e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.77e-06	2.07e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.77e-06	2.06e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.77e-06	2.06e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.75e-06	2.04e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.75e-06	2.03e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.62e-06	1.89e-05	CbGpPWpGaD
